No. | Document Title | ID | Updated | Views |
---|---|---|---|---|
321 | Fund Account No. | 101797 | 2022-11-29 | 343 |
322 | Sponsor Protocol No. | 101796 | 2022-11-29 | 263 |
323 | Sponsor Type | 101795 | 2022-11-29 | 317 |
324 | Staff: Stop Reason | 101793 | 2022-11-29 | 329 |
325 | Staff: Stop Date | 101792 | 2022-11-29 | 279 |
326 | Staff: Start Date | 101791 | 2022-11-29 | 285 |
327 | Protocol Staff Role | 70715 | 2022-11-29 | 387 |
328 | Managment Group | 101788 | 2022-11-29 | 319 |
329 | Toxicity Scheme | 24235 | 2022-11-25 | 385 |
330 | Pharmacy No. | 122680 | 2022-11-25 | 263 |
331 | IRB Committee | 101848 | 2022-11-17 | 240 |
332 | IRB: Submit Date | 101847 | 2022-11-17 | 283 |
333 | Subject MRN | 23831 | 2022-11-09 | 452 |
334 | Version Date | 99348 | 2022-10-05 | 286 |
335 | Verified By | 99349 | 2022-10-05 | 362 |
336 | Uses RC | 101825 | 2022-10-05 | 287 |
337 | Last Name | 99305 | 2022-10-05 | 262 |
338 | Race | 99312 | 2022-10-05 | 227 |
339 | Signed Date | 99338 | 2022-10-05 | 276 |
340 | Reconsent | 99341 | 2022-10-05 | 274 |
Not finding what you are looking for? Suggest a new document be created, or try adjusting your search criteria.